Cell type-specific in vivo expression of genes encoding signalling molecules in the brain in response to chronic mild stress and chronic treatment with fluoxetine
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Rationale Previously, we reported that chronic treatment with fluoxetine increased gene expression of 5-hydroxytryptamine receptor 2B (5-HT2BR), cytosolic phospholipase 2α (cPLA2α), glutamate receptor, ionotropic kainate 2 (GluK2) and adenosine deaminase acting on RNA 2 (ADAR2), in cultured astrocytes and astrocytes freshly isolated from transgenic mice tagged with an astrocyte-specific marker. In contrast, neurones isolated from transgenic mice tagged with a neurone-specific marker and exposed to fluoxetine showed an increase in gene expression of glutamate receptor, ionotropic kainate 4 (GluK4) and 5-hydroxytryptamine receptor 2C (5-HT2CR). In a mouse model of anhedonia, the downregulation of 5-HT2BR, cPLA2α, ADAR2 and GluK4 but not GluK2 and 5-HT2CR was detected. Objective To investigate the effects of chronic mild stress (CMS) and/or fluoxetine treatment on gene expression of 5-HT2BR, 5-HT2CR, cPLA2α, ADAR2, GluK2 and GluK4 specifically in astrocytes and neurones. Methods Transgenic mice tagged with either astrocyte- or neurone-specific markers were exposed to the CMS. Real-time PCR was applied to determine expression of messenger RNA (mRNA). Results We found that (i) mRNAs of the 5-HT2BR and cPLA2α in astrocytes and GluK4 in neurones were significantly reduced in mice that became anhedonic; the mRNA levels were restored by fluoxetine treatment; (ii) ADAR2 in astrocytes was decreased by the CMS but showed no response to fluoxetine in anhedonic animals; (iii) neither GluK2…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies on damage to microglia and astrocytes suggest the significance of glial cells in the development of environmental factor-induced depression-like behaviors in mice. 40”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [40]
Citations
Cites
1 retracted
Rao, J. S., Ertley, R. N., Lee, H.-J., Rapoport, S. I., & Bazinet, R. P. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500391 · Cited by 41
RetractedA new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Imaging Neuronal Subsets in Transgenic Mice Expressing Multiple Spectral Variants of GFP
Feng, G., Mellor, R. H., Bernstein, M., Keller-Peck, C., Nguyen, Q. T., Wallace, M., Nerbonne, J. M., Lichtman, J. W., & Sanes, J. R. (2000) · Neuron · doi:10.1016/s0896-6273(00)00084-2 · Cited by 3,042
Mayberg, H. S., Brannan, S. K., Tekell, J. L., Silva, J. A., Mahurin, R. K., McGinnis, S., & Jerabek, P. A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01036-2 · Cited by 1,115 · cited 1×
“2008), and the glucose metabolism is normalized by treatment with SSRI (Buchsbaum et al. 1997; Mayberg et al. 2000).”
BackgroundGliogenesis and Glial Pathology in Depression
Rajkowska, G., & Miguel-Hidalgo, J. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780619326 · Cited by 610
CHEN, C.-X., CHO, D.-S. C., WANG, Q., LAI, F., CARTER, K. C., & NISHIKURA, K. (2000) · RNA · doi:10.1017/s1355838200000170 · Cited by 524
The Transcriptome and Metabolic Gene Signature of Protoplasmic Astrocytes in the Adult Murine Cortex
Lovatt, D., Sonnewald, U., Waagepetersen, H. S., Schousboe, A., He, W., Lin, J. H.-C., Han, X., Takano, T., Wang, S., Sim, F. J., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3404-07.2007 · Cited by 489 · cited 2×
“A cell suspension was prepared as previously described (Lovatt et al. 2007).”
MethodVidebech, P. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.101001011.x · Cited by 419
Beneyto, M., Kristiansen, L. V., Oni-Orisan, A., McCullumsmith, R. E., & Meador-Woodruff, J. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301312 · Cited by 408
Effect of sertraline on regional metabolic rate in patients with affective disorder
Buchsbaum, M. S., Joseph, W., Siegel, B. V., Hackett, E., Trenary, M., Abel, L., & Reynolds, C. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00097-2 · Cited by 303 · cited 1×
“2008), and the glucose metabolism is normalized by treatment with SSRI (Buchsbaum et al. 1997; Mayberg et al. 2000).”
BackgroundRegional cerebral glucose utilization in patients with a range of severities of unipolar depression
Kimbrell, T. A., Ketter, T. A., George, M. S., Little, J. T., Benson, B. E., Willis, M. W., Herscovitch, P., & Post, R. M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01216-1 · Cited by 301
Astroglial cradle in the life of the synapse
Verkhratsky, A., & Nedergaard, M. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0595 · Cited by 266 · cited 1×
“buffering and metabolism of principal neurotransmitters glutamate, GABA and adenosine (Hertz 2013; Verkhratsky and Nedergaard 2014).”
BackgroundSelf-citationGlial Physiology and Pathophysiology
Verkhratsky, A., & Butt, A. (2013) · Wiley eBooks · doi:10.1002/9781118402061 · Cited by 254
Self-citationHertz, L. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00059 · Cited by 234
Peng, P. L., Zhong, X., Tu, W., Soundarapandian, M. M., Molner, P., Zhu, D., Lau, L., Liu, S., Liu, F., & Lu, Y. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.025 · Cited by 230
Felder, C. C., Kanterman, R. Y., Ma, A. L., & Axelrod, J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2187 · Cited by 220
Association of GRIK4 With Outcome of Antidepressant Treatment in the STAR*D Cohort
Paddock, S., Laje, G., Charney, D., Rush, A. J., Wilson, A. F., Sorant, A. J. M., Lipsky, R., Wisniewski, S. R., Manji, H., & McMahon, F. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111790 · Cited by 192
A putative functional role for oligodendrocytes in mood regulation
Edgar, N., & Sibille, E. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.34 · Cited by 185
Shaltiel, G., Maeng, S., Malkesman, O., Pearson, B., Schloesser, R. J., Tragon, T., Rogawski, M., Gasior, M., Luckenbaugh, D., Chen, G., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.20 · Cited by 173
Association of GRIK4 With Outcome of Antidepressant Treatment in the STAR*D Cohort
Ballenger, J. C. (2009) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)79086-8 · Cited by 167
Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder
Altshuler, L. L., Abulseoud, O. A., Foland‐Ross, L., Bartzokis, G., Chang, S., Mintz, J., Hellemann, G., & Vinters, H. V. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00838.x · Cited by 166
Su, K.-P., Huang, S.-Y., Peng, C.-Y., Lai, H.-C., Huang, C.-L., Chen, Y.-C., Aitchison, K. J., & Pariante, C. M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.11.005 · Cited by 165
Update in the methodology of the chronic stress paradigm: internal control matters
Strekalova, T., Couch, Y., Kholod, N., Boyks, M., Malin, D., Leprince, P., & Steinbusch, H. M. (2011) · Behavioral and Brain Functions · doi:10.1186/1744-9081-7-9 · Cited by 163
Myelination and Oligodendrocyte Functions in Psychiatric Diseases
Nave, K.-A., & Ehrenreich, H. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.189 · Cited by 157
A review on animal models for screening potential anti-stress agents
Jaggi, A. S., Bhatia, N., Kumar, N., Singh, N., Anand, P., & Dhawan, R. K. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0770-6 · Cited by 150
The glial perspective of autism spectrum disorders
Zeidán‐Chuliá, F., Salmina, A. B., Malinovskaya, N. A., Noda, M., Verkhratsky, A., & Moreira, J. C. F. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.008 · Cited by 120
Self-citationInflammation: a mechanism of depression?
Han, Q.-Q., & Yu, J. M. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1439-3 · Cited by 118
Li, B., Zhang, S., Zhang, H., Nu, W., Cai, L., Hertz, L., & Peng, L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1306-5 · Cited by 115 · cited 1×
“Acute treatment of mouse astrocytes in primary cultures with the serotonin-specific reuptake inhibitor (SSRI) fluoxetine that is widely used to treat MD and obsessive-compulsive disorder activates a 5-hydroxytryptamine receptor 2B (5HT2B) receptor-mediated pathway leading to a release of growth factors, transactivatio…”
BackgroundSelf-citationBarbon, A., Popoli, M., Via, L. L., Moraschi, S., Vallini, I., Tardito, D., Tiraboschi, E., Musazzi, L., Giambelli, R., Gennarelli, M., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.018 · Cited by 104
Hertz, L. (2011) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2011.04.013 · Cited by 72
General Pathophysiology of Astroglia
Verkhratsky, A., Ho, M. S., Vardjan, N., Zorec, R., & Parpura, V. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-9913-8_7 · Cited by 66
Self-citationSerotonin receptor 2C and mental disorders: Genetic, expression, and RNA editing studies
Iwamoto, K., Bundo, M., & Kato, T. (2009) · RNA Biology · doi:10.4161/rna.6.3.8370 · Cited by 66
Fu, H., Li, B., Hertz, L., & Peng, L. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.04.010 · Cited by 63
Self-citationCatches, J. S., Xu, J., & Contractor, A. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.12.026 · Cited by 59 · cited 1×
“This is inconsistent with the observation that Grik4 knockout mice show an antidepressant phenotype (Paddock et al. 2007; Catches et al. 2012).”
ResultLi, B., Dong, L., Wang, B., Cai, L., Jiang, N., & Peng, L. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0814-1 · Cited by 58
Self-citationLi, B., Zhang, S., Zhang, H., Hertz, L., & Peng, L. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100094 · Cited by 54
Self-citationSR-141716A-induced stimulation of locomotor activity
Bass, C. E., Griffin, G., Grier, M. C., Mahadevan, A., Razdan, R. K., & Martin, B. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00945-0 · Cited by 53
Li, B., Zhang, S., Li, M., Hertz, L., & Peng, L. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1631-3 · Cited by 52
Self-citationLittle, J. T., Ketter, T. A., Kimbrell, T. A., Danielson, A., Benson, B., Willis, M. W., & Post, R. M. (1996) · PubMed · Cited by 45
Barbon, A., Orlandi, C., La Via, L., Caracciolo, L., Tardito, D., Musazzi, L., Mallei, A., Gennarelli, M., Racagni, G., Popoli, M., et al. (2011) · Neuropsychobiology · doi:10.1159/000321593 · Cited by 45 · cited 1×
“Although 5-HT2C receptor is edited by fluoxetine (Barbon et al. 2011), neither CMS nor fluoxetine affected ADAR2 expression in neurones.”
BackgroundPae, C., Yu, H.-S., Lee, K., Kim, J.-J., Lee, C., Lee, S.-J., Jun, T., Lee, C., & Paik, I. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.009 · Cited by 39
Hertz, L., Song, D., Li, B., Du, T., Xu, J., Gu, L., Chen, Y., & Peng, L. (2014) · Journal of Signal Transduction · doi:10.1155/2014/593934 · Cited by 27
Self-citationSeki, M., Nawa, H., Morioka, T., Fukuchi, T., Oite, T., Abe, H., & Takei, N. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00654-7 · Cited by 26 · cited 1×
“These transgenic mice combine a cellspecific marker with a specific fluorescent signal, allowing fluorescence-activated sorting of specified cell fractions, although it should be emphasized that Thy1 is mainly a marker of large projection neurones rather than a general neuronal marker (Feng et al. 2000; Seki et al. 20…”
BackgroundAffect-related behaviors in mice misexpressing the RNA editing enzyme ADAR2
Singh, M., Zimmerman, M. B., Beltz, T. G., & Johnson, A. K. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.03.029 · Cited by 26
Peng, L., Li, B., Du, T., Wang, F., & Hertz, L. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.021 · Cited by 24
Self-citationCerebral metabolic patterns in untreated postmenopausal women with major depressive disorder
Rasgon, N., Kenna, H. A., Geist, C. L., Small, G. W., & Silverman, D. H. S. (2008) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.12.006 · Cited by 23
Altered ADAR 2 equilibrium and 5HT2CR editing in the prefrontal cortex of ADAR 2 transgenic mice
Singh, M., Singh, M. M., Na, E., Agassandian, K., Zimmerman, M. B., & Johnson, A. K. (2011) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2011.00701.x · Cited by 19
Perez, L. J., de Arce, H. D., Cilloni, F., Salviato, A., Marciano, S., Perera, C. L., Salomoni, A., Beato, M. S., Romero, A., Capua, I., et al. (2012) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2012.02.001 · Cited by 16
Stein, E. J., da Silveira-Filho, N. G., Machado, D. C., Hipólide, D. C., Barlow, K. B. L., & Nóbrega, J. N. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.09.005 · Cited by 13
関, 正. (2003) · Medical Entomology and Zoology · Cited by 8
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
Self-citationAstrocytes in human central nervous system diseases: a frontier for new therapies
Verkhratsky, A., Butt, A., Li, B., Illes, P., Zorec, R., Semyanov, A., Tang, Y., & Sofroniew, M. V. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01628-9 · Cited by 428
“Treatment with fluoxetine upregulates expression of 5-HT2B receptors (which is decreased by chronic stress) selectively in astrocytes, and not in neurones.(433) More importantly however, fluoxetine acts as a powerful and specific agonist of astrocytic 5-HT2B receptors.”
BackgroundSelf-citationXia, M., Yang, L., Sun, G., Qi, S., & Li, B. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4473-9 · Cited by 149
Self-citationTranslational potential of astrocytes in brain disorders
Verkhratsky, A., Steardo, L., Parpura, V., & Montana, V. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.003 · Cited by 109
“Chronic treatment with antidepressants directly affected astroglia, by increasing expression of receptors and transporters responsible for CNS homeostasis and limiting glutamate release (Czeh and Di Benedetto, 2013; Dong et al., 2015; Liu et al., 2015; Ren et al., 2015).”
BackgroundSelf-citationElectroacupuncture prevents astrocyte atrophy to alleviate depression
Lin, S.-S., Zhou, B., Chen, B.-J., Jiang, R.-T., Li, B., Illes, P., Semyanov, A., Tang, Y., & Verkhratsky, A. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05839-4 · Cited by 102
“Mice were exposed to the random sequence of stressors during each 24-h period for 4 weeks, as previously described (Dong et al., 2015; Liang et al., 2020).”
Self-citation
Metadata
- Authors
- Dong, L., Li, B., Verkhratsky, A., & Peng, L.
- Affiliations
- China Medical University (CN)
- Ikerbasque (ES)
- Corresponding author
- Peng, Liang
- Venue
- Psychopharmacology
- Published
- 2015-04-09
- Volume
- 232
- Issue
- 15
- Pages
- 2827-2835
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2007107398
- Cited by
- 32
- References
- 50
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 5 · 2020: 2 · 2019: 5 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 2
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- chronic mild stress, fluoxetine, anhedonia, major depressive disorder, astrocytes, neurons, 5-HT2B receptor, 5-HT2C receptor, cytosolic phospholipase A2 alpha, ADAR2, GluK2, serotonin receptors, cell type-specific gene expression, transgenic mice
- MeSH terms
- Animals, Astrocytes, Brain, Female, Fluoxetine, Male, Mice, Transgenic, Neurons, RNA, Messenger, Serotonin, Stress, Psychological, Down-Regulation, Up-Regulation, Gene Expression, Selective Serotonin Reuptake Inhibitors, Mice, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.